NO752053L - - Google Patents

Info

Publication number
NO752053L
NO752053L NO752053A NO752053A NO752053L NO 752053 L NO752053 L NO 752053L NO 752053 A NO752053 A NO 752053A NO 752053 A NO752053 A NO 752053A NO 752053 L NO752053 L NO 752053L
Authority
NO
Norway
Prior art keywords
benzyloxy
tetrahydronaphthalene
hydroxy
amino
mixture
Prior art date
Application number
NO752053A
Other languages
English (en)
Norwegian (no)
Inventor
H Sugihara
M Watanabe
M Motohashi
M Nishikawa
Y Sanno
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP49067539A external-priority patent/JPS5833219B2/ja
Priority claimed from JP49137883A external-priority patent/JPS51125265A/ja
Priority claimed from JP814875A external-priority patent/JPS5186456A/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO752053L publication Critical patent/NO752053L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/74Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C215/84Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems
    • C07C215/86Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems being formed by two rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/38Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/20Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hydrogen atoms and substituted hydrocarbon radicals directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO752053A 1974-06-12 1975-06-10 NO752053L (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP49067539A JPS5833219B2 (ja) 1974-06-12 1974-06-12 テトラロ−ルカゴウブツノ セイゾウホウ
JP12353974 1974-10-25
JP49137883A JPS51125265A (en) 1974-11-29 1974-11-29 Process for preparing tetralone compounds
JP814875A JPS5186456A (ja) 1975-01-17 1975-01-17 Tetoraroorukagobutsuno seizoho

Publications (1)

Publication Number Publication Date
NO752053L true NO752053L (es) 1975-12-15

Family

ID=27454881

Family Applications (1)

Application Number Title Priority Date Filing Date
NO752053A NO752053L (es) 1974-06-12 1975-06-10

Country Status (11)

Country Link
US (1) US4035512A (es)
CA (1) CA1039297A (es)
CH (1) CH625780A5 (es)
DE (1) DE2525512A1 (es)
DK (1) DK254975A (es)
ES (2) ES438451A1 (es)
FI (1) FI751755A (es)
GB (1) GB1516331A (es)
NL (1) NL7506975A (es)
NO (1) NO752053L (es)
SE (1) SE7506687L (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3062971D1 (en) * 1979-09-14 1983-06-09 Sandoz Ag Derivatives of tetraline, their preparation and medicaments containing these compounds
US4530919A (en) * 1980-10-21 1985-07-23 Pfizer Inc. Carboxylic acid therapeutic agents
FR2512814A1 (fr) * 1981-09-16 1983-03-18 Synthelabo Derives d'amino-2 tetrahydro-1,2,3,4 naphtalene, leur preparation et leur application en therapeutique
JPS5970653A (ja) * 1982-10-15 1984-04-21 Takeda Chem Ind Ltd 眼圧低下剤
US4737519A (en) * 1983-12-14 1988-04-12 The Upjohn Company Substituted naphthalenes, indoles, benzofurans, and benzothiophenes as lipoxygenase inhibitors
IL79323A (en) * 1985-07-10 1990-03-19 Sanofi Sa Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
JPH0696521B2 (ja) * 1986-01-31 1994-11-30 千寿製薬株式会社 眼局所投与用眼圧降下剤
US4975461A (en) * 1986-06-19 1990-12-04 E. R. Squibb & Sons, Inc. P-aminophenols, derivatives thereof and method of use
DE3623941A1 (de) * 1986-07-16 1988-01-28 Bayer Ag Substituierte amino-5,6,7,8-tetrahydronaphthyl-oxyessigsaeuren, verfahren zu deren herstellung sowie die verwendung als arzneimittel
IT1224405B (it) * 1987-12-23 1990-10-04 Simes Composti attivi sul sistema cardiovascolare
US5071875A (en) * 1989-09-25 1991-12-10 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
US5151446A (en) * 1989-09-25 1992-09-29 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
US5382596A (en) * 1993-08-05 1995-01-17 Whitby Research, Inc. Substituted 2-aminotetralins
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
US5770615A (en) * 1996-04-04 1998-06-23 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
US11590089B2 (en) 2017-12-04 2023-02-28 The Board Of Trustees Of The Leland Stanford Junior University Beta-2 selective adrenergic receptor agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2549684A (en) * 1948-09-29 1951-04-17 Upjohn Co Methoxy substituted 2-aminoindanols
US2549685A (en) * 1948-09-30 1951-04-17 Upjohn Co Dioxy substituted 2-aminoindanols
US3458577A (en) * 1966-06-23 1969-07-29 Sandoz Ag 6-amino-6,7,8,9-tetrahydro-5h-benzocyclohepten-5-ols
US3930022A (en) * 1972-07-03 1975-12-30 Squibb & Sons Inc Certain tetrahydronaphthalenes used in the treatment of cardiac arrhythmia

Also Published As

Publication number Publication date
NL7506975A (nl) 1975-12-16
DE2525512A1 (de) 1975-12-18
ES438451A1 (es) 1977-06-01
DK254975A (da) 1975-12-13
FI751755A (es) 1975-12-13
ES454747A1 (es) 1978-01-01
DE2525512C2 (es) 1987-11-26
US4035512A (en) 1977-07-12
AU8194375A (en) 1976-12-16
CH625780A5 (es) 1981-10-15
GB1516331A (en) 1978-07-05
SE7506687L (sv) 1975-12-15
CA1039297A (en) 1978-09-26

Similar Documents

Publication Publication Date Title
NO752053L (es)
JP2564462B2 (ja) 新規アリールアルキル(チオ)アミド化合物
JPS59225149A (ja) 殺生物性多環化合物,その合成法,その中間体,それを含有する製剤および医薬としてのその使用
US20060079707A1 (en) Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
AU4739290A (en) Alpha-heterocyclic ethanol aminoalkylindole derivatives
CA2033243C (en) Phenylethanolaminomethyltetralins
NZ270082A (en) N-naphthylethyl amide and urea derivatives; pharmaceutical compositions
AU2002234836A1 (en) Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
US5225596A (en) Halo substituted aminotetralins
PL90695B1 (es)
JP2611816B2 (ja) N−(ヒドロキシ)アラルキルフェニルエタノールアミン類のo−アルキル化方法
JPH06234711A (ja) オクタヒドロフェナンスレン誘導体
US3171858A (en) alpha-ethylamino-o-methylisobutyrophenone
US20190263815A1 (en) Processes for preparing tph1 inhibitors
CA2061311A1 (en) New phenylethanolamino- and phenylethanolaminomethyltetralines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them
KR880001814B1 (ko) 2'-치환된-스피로[벤조푸란-2(3h),1'-사이클로알칸] 및 그의 제조방법
IL123156A (en) Derivatives of benzenesulfonamide, their preparation and pharmaceutical preparations containing them
US2923714A (en) 1-picolinoyl-2-benzyl hydrazine and salts
DE2457971A1 (de) Verfahren zur herstellung von 2-acyl4-oxo-pyrazino-isochinolin-derivaten
JPS60185749A (ja) アラルキル(アリ−ルエチニル)アラルキルアミン類および血管拡張剤および抗高血圧剤としてのそれらの使用
NO752138L (es)
US6906192B2 (en) Processes for the preparation of acid derivatives useful as serine protease inhibitors
JP3216912B2 (ja) 2−アザビシクロ[2.2.1]ヘプト−5−エン−3−オンの製造法
GB1568976A (en) Cis-4-phenyl-isoquinolines
JPS5833219B2 (ja) テトラロ−ルカゴウブツノ セイゾウホウ